By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Certara Corporation 

St. Louis  Missouri    U.S.A.
Phone: n/a Fax: n/a



Company News
Japanese Regulatory Agency Licenses Certara Corporation’s Phoenix And Simcyp Software To Support Model-Based Drug Development 2/26/2015 11:00:41 AM
Certara Corporation Promotes Professor Amin Rostami To Senior Vice President Of R&D And Chief Scientific Officer 1/29/2015 1:34:17 PM
Certara Corporation Appoints Gavin Nichols As President Of Technology And Head Of Its Software Business Unit 1/20/2015 11:31:56 AM
Synchrogenix, Certara Corporation’s Regulatory And Medical Writing Consultancy, Acquires ClinGenuity 1/6/2015 11:11:05 AM
Certara Corporation Updates Its Simcyp Simulator Used To Predict Drug Behavior In Virtual Patient Populations 11/19/2014 9:52:55 AM
Certara Corporation Receives FDA Grant To Enhance Simcyp Simulator’s Mechanistic Dermal Absorption Model To Permit Drug Bioequivalence Assessment 10/23/2014 10:03:08 AM
Certara Corporation’s New Muse Invent Allows Chemistry Researchers To Design Drug Candidates That Are Synthetically Feasible 8/11/2014 8:19:54 AM
Certara Corporation Launches D360 In Japan To Improve Drug Discovery And Development Productivity 8/4/2014 11:09:07 AM
Certara Corporation Taps Dr. Edmundo Muniz For CEO Post 6/5/2014 6:32:05 AM
Certara Corporation Introduces Pre-Clinical Safety Store To Capture And Validate File-Based Study Data In A CDISC-SEND Database 4/29/2014 9:48:28 AM